تم إعطاء epoetin بجرعة 8,000 IU ثلاث مرات أسبوعياً لمدة شهرين إلى 30 مريض أورام لعلاج فقر الدم لديهم. تم معايرة الإريتروبويتين قبل العلاج و مراقبة الخضاب و المشعرات الدموية أثناء العلاج . تحققت الاستجابة عند 53% من المرضى, و كان معدل الاستجابة أعلى عند وجود انخفاض في مستوى الإريتروبويتين ( 100 U/L) (71% مقابل 27%) .
كما كان معدل الاستجابة أعلى عند المصابين بأورام غير صلبة مقارنة مع الأورام الصلبة ( 80 % مقابل 39% ).
كان متوسط ارتفاع الشبكيات بعد أسبوعين أعلى عند المرضى المستجيبين مقارنة مع غير المستجيبين .كان معدل الاستجابة أعلى عندما كان تحسن الخضاب بعد أسبوعين < 0.5 g/dL نسبة للخضاب البدئي (83 % مقابل 31%) و عندما كان تحسن الخضاب بعد 4 أسابيع < 1 g/dL نسبة للخضاب البدئي (93% تقريباً مقابل 14%).
يمكن التنبؤ بالاستجابة على العلاج بالإريتروبويتين من خلال القيمة المصلية للإريتروبويتين قبل العلاج بالمشاركة مع التغيرات الباكرة في المشعرات الدموية الأخرى .
we delivered 8,000 IU epoetin three times per week to 30 anemic cancer patients for two months.we measured serum erythropoietin level before the initiation of the treatment.Hemoglobin concentration and other hematological parameters were measured during the treatment. 53% of patients responded to the treatment within 8 weeks. 71% of patients with serum erythropoietin < 100 U/L responded, whereas 27% with values > 100 U/L did.80% of patients with hematological malignancies responded, whereas 39% of patients with solid tumors did .Reticulocyte increment after two weeks in responder patients was higher than non responders.response rate was higher in patients with Hb increment > 0.5 g/dL after 2 weeks ( 83% versus 31% ), and in those with Hb increment > 1 g/dL after 4 weeks ( 93% versus 14% ). response to erythropoietin can be predicted by pretreatment serum erythropoietin level together with early changes in other hematological parameters.
References used
VOGELZANG, NJ; BREITBAT, W; CELLA, D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. SeminHematol,34(suppl 2), 1997,4-12
ASHBURY, FD; FINDLAY, H; REYNOLDS, B, et al. A Canadian survey of cancer patients’ experiences: Are their needs being met? J Pain Symptom Manage,16, 1998, 298 –306
CELLA, D. The Functional Assessment of Cancer Therapy-Anemia (FACTAn) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol,34(suppl 2), 1997,13–19
The study aimed to demonstrate the importance of applying PH- METRY test in the diagnosis of gastroesophageal reflux disease(GERD) of children with recurrent respiratory diseases, to determine the most common digestive and other clinical symptoms(res
Lung cancer is the major cause of cancer death. S100A7
overexpression has been associated with early stages of
carcinomas . This study aimed to evaluate the levels of serum
S100A7 in lung cancer. Our study contains 63 patients of lung
cancer (46
This study included 502 children between 0,5-15 years old. They were all subjected to duodenal biobsy for several reasons, and underwent investigations; Hb, MCV, MCH, MCHC and RDW.
The prevalence of celiac disease among anemic children was higher
Objective:
Evaluate sensitivity and specificity of nitrite test to urine culture(gold standard) for
diagnosing urinary tract infection in patients with sickle cell anemia with urinary
symptoms and signs.
Methods:
The study sample included 79 chi
In this study : 30 patients with metastatic prostate cancer who admitted to the
department of Oncology, Tishreen University Hospital, Lattakia, Syria between 2013
and 2014 were grouped according to gleason score , age and body mass index.
All pati